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Brain natriuretic peptide (BNP) is used to guide therapy in patients with heart failure. The utility of monitoring BNP in continuous flow left ventricular 
assist device (CF-LVAD) recipients is unclear. We analyzed whether pre-VAD to 90 day (90d) change (Δ) in BNP was associated with readmission. 
From April 2009 to October 2013, we retrospectively analyzed BNP variation and readmissions in 62 patients (53±11 years, 79% male) implanted 
with a CF-LVAD (HeartMate II n=43, 69%, HeartWare n=19, 31%). Patients were analyzed according to 3 readmission groups: 34 patients (55%) 
accounted for 52 readmissions (ALL group). Within this group, 11 patients had 14 cardiac readmissions (CARD group), and 28 patients had 38 
non-cardiac readmissions (Non-CARD group). Univariate analysis comparing BNP profiles for each readmission group revealed the CARD group had 
less reduction in BNP levels at 90d (p=0.02), whereas no difference was observed for the other 2 groups (all p>0.05). However, after adjusting for 
differences in each readmission group (age, creatinine, pump speed and device type), multivariate analysis revealed that although the ALL group was 
associated with less reduction in BNP level at 90d (OR 1.71, p=0.02, Figure 1), the CARD group had the strongest association with readmission (OR 
5.87, p=0.01). Less reduction in BNP levels after CF-LVAD implantation predicts cardiac related readmissions. Goal-directed BNP monitoring after 
CF-LVAD may improve clinical outcomes and warrants further investigation. 
